Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

  • This share is currently suspended. It was suspended at a price of 0.01
  • There is currently no data for VRS

Graphinks Product Launch

8 Jun 2018 07:00

RNS Number : 7061Q
Versarien PLC
08 June 2018
 

Versarien plc

("Versarien" or the "Company")

Graphinks Product Launch

 

Versarien plc (AIM: VRS), the advanced materials engineering group, is pleased to announce the formal launch of Graphinks, the latest addition to Versarien's range of commercially available 2D materials.

 

Graphinks has recently been trademarked by Versarien and is the brand under which the Company's range of proprietary graphene inks will be marketed. Produced by the Company's subsidiary Cambridge Graphene, Graphinks is a range of high performance, electrically conductive, graphene inks suitable for a wide range of printing processes, substrates and applications, including flexible electronics and antennas.

 

Graphinks are produced using a scalable production process, developed at the Cambridge Graphene Centre, University of Cambridge. The production process allows for a range of ink formulations to be manufactured in order to meet the requirements of different printing methods and substrates. Graphinks are aqueous, environmentally friendly and non-toxic.

 

Graphinks is the latest formal addition to Versarien's high performance 2D material product range, alongside Nanane, a high purity, low defect graphene and Hexotene, a few layer hexagonal boron nitride (h-BN) nanoplatelet powder with large lateral dimensions. The range is further supported by few layer graphene and graphene oxide powders suitable for a wide range of industrial applications.

 

Commenting, Neill Ricketts, CEO of Versarien stated: "The introduction of Graphinks into our stable of 2D materials further widens the ability of Versarien to deliver innovative solutions for industry. There are numerous potential applications for Graphinks, which can be customised to meet the individual requirements of customers, and we anticipate substantial commercial demand."

 

Enquiries:

Versarien

Neill Ricketts, CEO

Chris Leigh, CFO

01242 269 122

Arden Partners (Nominated Adviser and Broker)

Chris Hardie

Dan Gee-Summons

020 7614 5900

IFC Advisory (Financial PR and IR)

Tim Metcalfe

Graham Herring

Heather Armstrong

020 3934 6630

 

About Versarien

 

Versarien plc (AIM:VRS), is an advanced engineering materials group. Leveraging proprietary technology, the Group creates innovative engineering solutions for its clients in a diverse range of industries. Versarien has five subsidiaries operating under two divisions:

 

Graphene and Plastics

 

2-DTech Ltd, which specialises in the supply, characterisation and early stage development of graphene products. www.2-dtech.com

 

AAC Cyroma Ltd, which specialises in the supply of vacuum-formed and injection-moulded products to the automotive, construction, utilities and retail industry sectors. Using Versarien's existing graphene manufacturing capabilities, AAC will have the ability to produce graphene-enhanced plastic products. www.aaccyroma.co.uk

 

Cambridge Graphene Ltd, which supplies novel inks based on graphene and related materials, using patented processes and develops graphene materials technology for licensing to manufacturers. www.cambridgegraphene.com

 

Thermal and Hard Wear Products

 

Versarien Technologies Ltd. which has developed an additive process for creating advanced micro-porous metals targeting the thermal management industry and supplies extruded aluminium. www.versarien-technologies.co.uk

 

Total Carbide Ltd, a leading manufacturer in sintered tungsten carbide for applications in arduous environments such as the oil and gas industry. www.totalcarbide.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAGMGGVVNFGRZM
Date   Source Headline
12th Dec 20249:59 amRNSHolding(s) in Company
11th Dec 20241:21 pmRNSHolding(s) in Company
4th Dec 20247:00 amRNS-RInvestor Presentation
27th Nov 20244:45 pmRNSHolding(s) in Company
26th Nov 20243:42 pmRNSHolding(s) in Company
21st Nov 202411:12 amRNSUpdate on Legal Claims
4th Nov 202412:07 pmRNSHolding(s) in Company
1st Nov 20247:00 amRNSTotal Voting Rights
31st Oct 202410:36 amRNSUpdate on Sale of Korean Assets
31st Oct 202410:14 amRNSHolding(s) in Company
18th Oct 202410:41 amRNSHolding(s) in Company
16th Oct 20247:00 amRNSPlacing to raise £450,000
4th Oct 20247:00 amRNSCorporate Update
30th Sep 20247:00 amRNSDisposal of AAC Cyroma Limited
14th Aug 20247:00 amRNS3D Construction Printing Contract
5th Aug 20241:16 pmRNSHolding(s) in Company
2nd Aug 202410:48 amRNSUpdate on Sale of Korean Assets
31st Jul 20242:30 pmRNSTotal Voting Rights
29th Jul 20241:47 pmRNSHolding(s) in Company
24th Jul 20247:00 amRNSPlacing to raise £550,000
18th Jul 20247:00 amRNSUpdate on Legal Claims
17th Jul 20247:00 amRNSConversion of Gnanomat Loan
6th Jun 20247:00 amRNSInterim Results for six months ended 31 March 2024
30th Apr 202411:59 amRNSResult of AGM
28th Mar 20247:00 amRNSAudited Results for year ended 30 September 2023
28th Mar 20247:00 amRNSTotal Voting Rights
20th Mar 20248:33 amRNSPlacing to raise £615,000
14th Mar 20247:00 amRNSSouth American Graphinks Agreements
11th Mar 20247:00 amRNSSale of Korean Assets and Licencing of IP
16th Feb 20242:22 pmRNSNotification of final results
7th Feb 20247:00 amRNSReceipt of Legal Claims
31st Jan 20247:00 amRNSTotal Voting Rights
23rd Jan 20244:53 pmRNSHolding(s) in Company
23rd Jan 20241:24 pmRNSHolding(s) in Company
19th Jan 20247:00 amRNSPlacing to raise £400,000
10th Jan 202411:29 amRNSResult of General Meeting
20th Dec 20237:00 amRNSCompany Update and Notice of General Meeting
30th Nov 20237:00 amRNSTotal Voting Rights
8th Nov 20237:00 amRNSPlacing to raise £454,822
30th Oct 202311:52 amRNSResult of General Meeting
30th Oct 20237:00 amRNSGeneral Meeting Statement
12th Oct 20237:00 amRNSNotice of General Meeting
2nd Oct 20237:00 amRNSCorporate Update
13th Sep 20237:00 amRNSTurnaround Strategy - Gnanomat Grant Award
31st Jul 20237:00 amRNSTotal Voting Rights
18th Jul 20234:31 pmRNSDirectorate Changes
14th Jul 20237:00 amRNSPlacing to raise £650,000
4th Jul 202310:54 amRNSResult of General Meeting
4th Jul 20237:00 amRNSGeneral Meeting Statement
15th Jun 20237:00 amRNSNotice of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.